<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/170084</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Biochemistry</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Estrogen represses <italic>Tgfbr1</italic> and <italic>Bmpr1a</italic> expression via estrogen receptor beta in MC3T3-E1 cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>He</surname><given-names>Hanliang</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Chunqing</given-names></name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tang</surname><given-names>Qifeng</given-names></name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yang</surname><given-names>Fan</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9826-4324</contrib-id>
<name><surname>Xu</surname><given-names>Youjia</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">&#x2217;</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Department of Orthopaedics, the Second Affiliated Hospital of Soochow University</institution>, Suzhou 215004, <country>China</country></aff>
<aff id="a2"><label>2</label><institution>Department of Orthopaedics, the Affiliated Hospital of Guizhou Medical University</institution>, Guiyang550004, <country>China</country></aff>
<aff id="a3"><label>3</label><institution>The Benq Medical Center of Suzhou</institution>, Suzhou 215000, <country>China</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x2217;</label> Correspondence to: Youjia Xu Email: <email>xuyoujia@medmail.com.cn</email> Telephone: &#x002B;86-0512-67783346 Fax: &#x002B;86-0512-67783346</corresp>
</author-notes>
<pub-date pub-type="epub"><year>2017</year></pub-date>
<elocation-id>170084</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>29</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>7</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2017, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="170084.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Abstract</title>
<p>MC3T3-E1 is a clonal pre-osteoblastic cell line derived from newborn mouse calvaria, which is commonly used in osteoblast studies. To investigate the effects of estrogen on osteoblasts, we treated MC3T3-E1 cells with various concentrations of estrogen and assessed their proliferation. Next, we performed RNA deep sequencing to investigate the effects on estrogen target genes. <italic>Bmpr1a</italic> and <italic>Tgfbr1</italic>, important participants in the TGF-beta signaling pathway, were down-regulated in our deep sequencing results. Bioinformatics analysis revealed that estrogen receptor response elements (EREs) were present in the <italic>Bmpr1a</italic> and <italic>Tgfbr1</italic> promoters. Culturing the cells with the estrogen receptor (ER) alpha or beta antagonists 1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride (MPP) or 4-[2-phenyl-5,7-bis(trifluoromethyl) pyrazolo[1,5-alpha]pyrimidin-3-yl] phenol (PTHPP), respectively, demonstrated that ER beta is involved in the estrogen-mediated repression of <italic>Tgfbr1</italic> and <italic>Bmpr1a</italic>.The chromatin immunoprecipitation (ChIP) results were consistent with the conclusion that E2 increased the binding of ER beta at the EREs located in the <italic>Tgfbr1</italic> and <italic>Bmpr1a</italic> promoters. Our research provides new insight into the role of estrogen in bone metabolisms.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Key words</title>
<kwd>Estrogen</kwd>
<kwd>Estrogen receptor beta</kwd>
<kwd><italic>Tgfbr1</italic></kwd>
<kwd><italic>Bmpr1a</italic></kwd>
</kwd-group>
<counts>
<page-count count="28"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Estrogen, a steroid hormone in the human body, plays an important role in many physiological processes [<xref ref-type="bibr" rid="c1">1</xref>, <xref ref-type="bibr" rid="c2">2</xref>], such as the maintenance of secondary sexual characteristics [<xref ref-type="bibr" rid="c3">3</xref>], the development of neurons [<xref ref-type="bibr" rid="c4">4</xref>], and bone homeostasis [<xref ref-type="bibr" rid="c5">5</xref>]. Estrogen is critical to maintain bone and bone density [<xref ref-type="bibr" rid="c6">6</xref>]. Estrogen deficiency often leads to the emergence of osteoporosis. In postmenopausal women, estrogen secretion is markedly reduced, as is bone mineral density, whereas the incidence of bone fractures is increased. This form of osteoporosis is called postmenopausal osteoporosis (PO) [<xref ref-type="bibr" rid="c7">7</xref>]. An imbalance of osteoblasts and osteoclasts in the bone causes osteoporosis [<xref ref-type="bibr" rid="c8">8</xref>]. PO has become one of the most important diseases that affects older women, as it entails huge financial burdens for individuals and society, and reduces the quality of life [<xref ref-type="bibr" rid="c9">9</xref>].</p>
<p>In 1988, Komm et al. found that ERs are expressed in osteoblasts [<xref ref-type="bibr" rid="c10">10</xref>], suggesting that estrogen may have a regulatory role for osteoblasts. After the discovery of ERs on osteogenic precursors and bone cells, an increasing number of studies has shown that estrogen has a direct effect on osteogenesis, as well as an indirect effect that does not depend on ERs. Kousteni et al. and others have found that estrogen can inhibit osteoblast apoptosis and prolong osteoblast life, thereby increasing the osteogenic capacity of each osteoblast [<xref ref-type="bibr" rid="c11">11</xref>]. The effect of estrogen is achieved by rapid activation of ER-mediated regulatory kinases [<xref ref-type="bibr" rid="c12">12</xref>]. The lack of estrogen causes a marked increase in NF-&#x03BA;B activity in osteoblasts [<xref ref-type="bibr" rid="c13">13</xref>]. Estrogen deficiency leads to an imbalance in bone metabolism between bone formation and resorption, eventually leading to osteoporosis. As the mechanism is not yet clear, further studies on estrogen regulation of bone metabolism and its signaling pathways are required to achieve a better understanding.</p>
<p>MC3T3-E1 cells are a clonal pre-osteoblastic cell line derived from newborn mouse calvarias, which is utilized in many osteoblast studies [<xref ref-type="bibr" rid="c14">14</xref>]. To investigate the effects of estrogen on osteoblasts, we treated MC3T3-E1 cells with various concentrations of estrogen (17-&#x03B2; estradiol, E2), then monitored their proliferation and apoptosis; we then conducted RNA deep sequencing to investigate estrogen target genes. From the differentially expressed genes (DEGs) in the estrogen-treated groups compared with the DMSO control, we chose <italic>Tgfbr1</italic> and <italic>Bmpr1a</italic> as candidate genes, as they play important roles in the transforming growth factor beta (TGF-&#x03B2;) and bone morphogenetic protein (BMP) signaling pathways. Promoter analysis revealed estrogen receptor response elements (ERE) in the <italic>Tgfbr1</italic> and <italic>Bmpr1a</italic> promoter regions. Using the ER&#x03B1; or ER&#x03B2; antagonists 1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride (MPP) or 4-[2-phenyl-5,7-bis(trifluoromethyl) pyrazolo[1,5-&#x03B1;]pyrimidin-3-yl] phenol (PTHPP), respectively, demonstrated that ER&#x03B2; is involved in the repression of estrogen in the regulation of <italic>Tgfbr1</italic> and <italic>Bmpr1a</italic>.The chromatin immunoprecipitation(ChIP) results were consistent with the conclusion that E2 increased binding to the EREs located in the <italic>Tgfbr1</italic> and <italic>Bmpr1a</italic> promoters. Thus, we conclude that estrogen affects bone through negative regulation of <italic>Tgfbr1</italic> and <italic>Bmpr1a</italic> in MC3T3-E1 cells. Our research provides new view insight into the mechanisms of action of estrogen on osteoblasts.</p></sec>
<sec id="s2">
<title>Materials &#x0026; Methods</title>
<sec id="s2a">
<title>Cell culture</title>
<p>The clonal murine pre-osteoblastic cell line MC3T3-E1 was used in this study. The cells were thawed from frozen stocks and cultured in 100-mm culture dishes in &#x03B1;-MEM supplemented with 10&#x0025; (v/v) fetal bovine serum (Gibco), 1&#x0025; (w/v) antibiotics/antimycotics (the stock solution contained 100 U/mL penicillin G sodium, 100 &#x03BC;g/mL streptomycin sulfate, and 0.25 &#x03BC;g/mL amphotericin B, in saline), 1.0 mM sodium pyruvate, 0.1 mM nonessential amino acids, and 1.5 g/L sodium bicarbonate (Gibco) at 37&#x00B0;C in a humidified atmosphere containing 5&#x0025; (v/v) CO<sub>2</sub>. After establishing cultures from frozen cells, we sub-cultured the cells several times. Confluent cells were detached using 0.25&#x0025; trypsin in Mg<sup>2&#x002B;</sup>- and Ca<sup>2&#x002B;</sup>-free phosphate-buffered saline (PBS) before use. For the treatment of MC3T3-E1 with E2, the cells were seeded in each well of a 24- or 6-well plate with 0.5 or 2mL of culture medium. The cells were incubated in the presence of E2 at different concentrations (0.01, 0.1, 1, and 10nM), and each concentration of E2 was maintained for three days. A group that received DMSO served as the control.</p></sec>
<sec id="s2b">
<title>Cell apoptosis assay</title>
<p>Cell apoptosis of MC3T3-E1 cells was analyzed with the TUNEL Apoptosis Detection Kit (Beyotime). Briefly, the cells were collected two days after treatment with E2, washed with PBS, and suspended in 500&#x03BC;l binding buffer. Then, the cells were stained for the detection of apoptosis, according to the manufacturer&#x2019;s instructions. The ratio of apoptotic cells was analyzed under an optical microscope by counting terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positive cells in six randomly selected areas.</p></sec>
<sec id="s2c">
<title>Total mRNA extraction</title>
<p>Total cell mRNA was extracted using TRIzol<sup>&#x00AE;</sup>, according to manufacturer instruction (Invitrogen). Smart Spec Plus (Bio-Rad) was used to measure the absorption at 260/280 nm to assess the quality and quantity of the collected RNA. Lastly, the integrity of the extracted RNA was further assessed using 1.5&#x0025; agarose gel electrophoresis. Subsequently, the RNA was transcribed to first strand cDNA using the First Strand cDNA Synthesis Kit (Takara) for gene expression analysis.</p></sec>
<sec id="s2d">
<title>RNA sequencing ibrary construction and sequencing</title>
<p>We used 20&#x03BC;g of total RNA from the control group and the10 nM E2-treated group for the RNA sequencing (RNA-seq) library preparation. The collected mRNA was purified and concentrated using oligo (dT)-conjugated magnetic beads (Invitrogen) before library preparation. The purified mRNA was randomly cut into fragments with the fragmentation buffer. We used the mRNA as a template, with 6-base random primers (random hexamers), to synthesize the first strand of cDNA. We then added dNTPs, RNase H, and DNA polymerase I to the buffer, to synthesize the second strand of cDNA. Lastly, we used AMPure<sup>&#x00AE;</sup> XP beads (Beckman) to purify the synthesized cDNA. The purification of double-stranded cDNA was performed with end repair and A-tailing. The AMPure<sup>&#x00AE;</sup> XP beads were used to select the size of the fragments. Finally, the cDNA library was obtained by PCR. Using &#x201C;sequencing by synthesis&#x201D; technology, we sequenced the cDNA libraries with the Illumina HiSeq2500 high-throughput sequencing platform and obtained high-quality reads. The reads and bases sequenced by the platform were usually considered raw data, and most of them got a Q30 score for base quality.</p></sec>
<sec id="s2e">
<title>Analysis of DEGs</title>
<p>Gene expression has time-and space-specific characteristics, and both external stimulation and the internal environment can affect gene expression. Under two different conditions (such as the control and treatment, wild-type and mutant, different times, different organizations, etc.), genes that have significantly different expression are considered DEGs. Similarly, transcripts with significantly different expression are called differentially expressed transcripts. In bioinformatics, the process of finding differentially expressed transcripts or DEGs is known as differential expression analysis.</p></sec>
<sec id="s2f">
<title>Annotation and analysis of DEGs</title>
<p>The Gene Ontology (GO) database was built in 2000, and is a standard, structured biological annotation system aimed at establishing a system of standard vocabulary and knowledge of genes and their products. The GO annotation system contains three main branches: biological process, molecular function, and cellular component. We used the GO database to predict the functions of the DEGs identified in this study[<xref ref-type="bibr" rid="c15">15</xref>]. Enrichment analysis of the differences between samples was carried out using Top GO. Top GO directly displays the GO node and the hierarchical relationship of the DEGs. The Clusters of Orthologous Groups (COG) of proteins database is constructed on the basis of the phylogeny of bacteria, algae, and eukaryotes to classify the orthologues of gene products. To annotate the pathways of the DEGs, it is necessary to analyze the functions of the genes. The Kyoto Encyclopedia of Genes and Genomes (KEGG) database is a major metabolic pathways database[<xref ref-type="bibr" rid="c16">16</xref>]. The analysis of the over-presentation of the DEGs in a pathway is important to determine the functions of the genes. In our study, COG and KEGG were used to analyze the DEGs.</p></sec>
<sec id="s2g">
<title>Quantitative real-time PCR (qRT-PCR) validation</title>
<p>Total cell mRNA was extracted using TRIzol<sup>&#x00AE;</sup>, according to manufacturer instruction (Invitrogen). We subjected 10&#x03BC;g of total RNA to DNaseI treatment with 1 U DNaseI (NEB). The reaction was carried out at 37&#x00B0;C for 10 min followed by heat inactivation at 65&#x00B0;C for10 min. We then used 2.5&#x03BC;g of DNase-treated RNA for cDNA synthesis with reverse transcriptase (Bio-Rad), in accordance with the manufacturer&#x2019;s protocol. The expression of the <italic>Gapdh</italic> gene, which the transcriptome database indicated was stable, was used as the control for qRT-PCR experiments. Primers were designed for selected transcripts from the transcriptome database and real-time PCR was performed with SYBR<sup>&#x00AE;</sup>Green I master mix (TAKARA) on a CFX Connect &#x2122; Real-Time PCR Detection System (Bio-Rad). The relative expression of the transcripts was calculated using the &#x0394; &#x0394; Ct method. The primers are shown in <xref ref-type="table" rid="tbl1">Table 1</xref>.</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1</label>
<caption><p>The primer of list in this paper</p></caption>
<graphic xlink:href="170084v1_tbl1.tif"/>
</table-wrap>
</sec>
<sec id="s2h">
<title>ER&#x03B1; and ER&#x03B2; antagonist treatment of MC3T3-E1 cells</title>
<p>For the ER&#x03B1; and ER&#x03B2; antagonist experiments, the ER&#x03B1; antagonist MPP and the ER&#x03B2; antagonist PTHPP were added to the MC3T3-E1 cultures. After 72 h of treatment with the antagonists, the cells were harvested to quantify the target gene expression.</p></sec>
<sec id="s2i">
<title>Chip assays</title>
<p>ChIP assays were performed according to the manufacturer&#x2019;s protocol (ChIP Assay Kit, Millipore). Briefly, MC3T3-E1 cells were collected after culture with or without E2, cross-linked in 2&#x0025; formaldehyde at 28<sup>0</sup>C for 30 min, then treated with a 1/10 volume of 1.25 M glycine to stop cross-linking, followed by PBS washes (three washes for 10 min each). We used purified rabbit or mouse IgG (Invitrogen) as a negative control and an antibody against ER&#x03B2; to pull down the DNA. We performed ChIP PCR using primers flanking the ERE sites, as well as primers not flanking the ERE sites in the promoter regions of <italic>Tgfr1</italic> and <italic>Bmpr1a</italic> as controls. The primers used for the ChIP PCR are listed in <xref ref-type="table" rid="tbl1">Table 1</xref>.</p></sec>
<sec id="s2j">
<title>Statistics</title>
<p>Data are presented as mean&#x00B1; standard deviation. Statistical differences between two groups were determined with Student&#x2019;s t test. Statistical differences among groups were analyzed with a one-way ANOVA followed by Student&#x2019;s test. All experiments were repeated at least three times, and representative experiments are shown. Differences were considered significant at P&#x003C;0.05.</p>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>E2 increased MC3T3-E1 cell proliferation</title>
<p>To determine if estrogen affects MC3T3-E1proliferation, we treated MC3T3-E1 cells with different concentrations of E2 (0, 0.01, 0.1, 1, and 10nM E2). We then performed CCK-8 experiments. We found that MC3T3-E1 cell proliferation was unchanged in the low concentration E2-treated groups (0.01 and 0.1 nM E2) compared with that in the DMSO control groups (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). However, in the high concentration E2 groups (1 and 10nM E2), MC3T3-E1 cell proliferation was significantly higher than in the DMSO control groups (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). These data revealed that high concentrations of E2 promote MC3T3-E1 cell proliferation. In order to obtain robust data and explore the mechanisms of action of estrogen on MC3T3-E1 cells, we next analyzed cells treated with the highest, supraphysiological concentration of E2 (10 nM) by RNA-seq, to explore the mechanisms of action of estrogen on MC3T3-E1 cells.</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1</label>
<caption>
<p>The effects of estrogen on MC3T3-E1 proliferation. MC3T3-E1cells were treated with different concentrations of E2, then subjected to analysis with a CCK-8 assay. Student&#x2019;s t-test. <sup>&#x2217;</sup>, P&#x003C;0.05; <sup>&#x2217;&#x2217;</sup>P&#x003C;0.01.</p></caption>
<graphic xlink:href="170084v1_fig1.tif"/>
</fig>
</sec>
<sec id="s3b">
<title>RNA-seq and identification of DEGs</title>
<p>To assess the effects of E2 on gene transcription, we used the Cuffdiff analysis module Cufflinks to analyze the differential gene expression in the samples [<xref ref-type="bibr" rid="c17">17</xref>]. The screening criteria for significant differences in the expression of genes are |log2Ratio| &#x2265; 1 and q-value&#x2264; 0.05. Using these criteria, we identified 460 DEGs. Among those DEGs, 66 genes were up-regulated and 394 genes were down-regulated in the cells treated with 10 nM E2 treated group (<xref ref-type="fig" rid="fig2">Fig. 2</xref>).</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2</label>
<caption>
<p>The RNA-seq identified DEGs. The screening criteria to identify significant differences in the expression of genes are |log2Ratio|&#x2265;1 and q-value&#x2264;0.05.</p></caption>
<graphic xlink:href="170084v1_fig2.tif"/>
</fig>
</sec>
<sec id="s3c">
<title>GO analysis and KEGG pathway functional analysis of enriched DEGs</title>
<p>GO is an internationally standardized gene functional classification system that provides a set of dynamically updated vocabularies to comprehensively describe the properties of genes and gene products in organisms. The most enriched GO results for the three ontologies are shown in <xref ref-type="table" rid="tbl2">Table 2</xref>. We found that genes that affect biological regulation, metabolic processes, development, anatomical structure development, responses to stimulation, systems development, cell differentiation, cell communication, regulation of gene expression, and signal transduction were enriched in the DEGs (<xref ref-type="table" rid="tbl2">Table 2</xref>).</p>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2</label>
<caption><p>Gene ontology enriched by differentially expression genes.</p></caption>
<graphic xlink:href="170084v1_tbl2.tif"/>
</table-wrap>
<p>Multiple genes coordinate their biological functions in vivo. Pathway-based analysis enables further understanding of the biological functions of the genes. KEGG is the main public pathway database. Because we focus on the bone metabolism process, so bone metabolisms pathway was come into our view. We found that the DEGs were enriched for genes involved in the pathways for cancer, MAPK signaling, TGF-&#x03B2; signaling, focal adhesion, Wnt signaling, NF-&#x03BA;B signaling, and osteoclast signaling (<xref ref-type="table" rid="tbl3">Table 3</xref>). The TGF-&#x03B2; and Wnt signaling pathways are important in osteoblasts. Through the pathway maps, we identified alterations in the expression of <italic>Bmpr1a</italic>, <italic>Tgfbr1</italic>, <italic>Rock1</italic>, and <italic>sp1</italic>, which are involved in the TGF-&#x03B2; signaling pathway (<xref ref-type="table" rid="tbl3">Table 3</xref>). We also noted alterations in the expression of <italic>Lrp5</italic>, <italic>Vangl2</italic>, and <italic>Rock1</italic>, which are involved in Wnt signaling (<xref ref-type="table" rid="tbl3">Table 3</xref>). In the cell cycle signaling pathway, we noted alteration in the expression <italic>Ccna2 Stag2</italic>, <italic>Atr</italic>, <italic>Smc1a</italic> and <italic>Rbl1.</italic> These data show that the effects of estrogen maybe mediated via the TGF-&#x03B2; and Wnt signaling pathways in MC3T3-E1 cells.</p>
<table-wrap id="tbl3" orientation="portrait" position="float">
<label>Table 3</label>
<caption><p>KEGG pathway enriched by differentially expression genes.</p></caption>
<graphic xlink:href="170084v1_tbl3.tif"/>
</table-wrap>
</sec>
<sec id="s3d">
<title>Confirmation of DEGs expression by qRT-PCR</title>
<p>We chose the candidate target genes from the bone metabolic signaling pathway. The candidate genes and their relative gene functions are listed in <xref ref-type="fig" rid="fig3">Fig. 3A</xref>. Among those genes, <italic>Sp1</italic>, <italic>Tgfbr1</italic>, and <italic>Rock1</italic> belong to the TGF-&#x03B2; signaling pathway; <italic>Bmpr1a</italic> belongs to the BMP signaling pathway; <italic>Fos</italic> is from the osteoclast differentiation pathway; <italic>Lrp6 is</italic> from the Wnt signaling pathway; and <italic>Adra1b</italic> belongs to the calcium signaling pathway. The qRT-PCR results indicated that <italic>Bmpr1a</italic> (<xref ref-type="fig" rid="fig3">Fig. 3B</xref>), <italic>Tgfbr1</italic> (<xref ref-type="fig" rid="fig3">Fig. 3C</xref>), <italic>Rock1</italic> (<xref ref-type="fig" rid="fig3">Fig. 3D</xref>), <italic>Lrp6</italic>, (<xref ref-type="fig" rid="fig3">Fig. 3F</xref>), and <italic>Sp1</italic>(<xref ref-type="fig" rid="fig3">Fig. 3H</xref>) were down-regulated by E2 treatment, whereas <italic>Fos</italic> (<xref ref-type="fig" rid="fig3">Fig. 3E</xref>) and <italic>Adra1b</italic> (<xref ref-type="fig" rid="fig3">Fig. 3G</xref>) were up-regulated. These results confirmed the differential expression after E2 treatment of the genes identified by RNA-seq.</p>
<fig id="fig3" position="float" fig-type="figure">
<label>Figure 3</label>
<caption>
<p>Confirmation of the mRNA levels of the DEGs by qRT-PCR. We treated MC3T3-E1 cells with 10 nM E2, then extracted total RNA for qRT-PCR. (A) The candidate genes involved in bone metabolism. (B) The expression level of <italic>Bmpr1a.</italic> (C) The expression level of <italic>Tgfbr1.</italic> (D) The expression level of <italic>Rock1.</italic> (E) The expression level of <italic>Fos.</italic> (F) The expression level of <italic>Lrp6.</italic> (G) The expression level of <italic>Adra1b.</italic> (H) The expression level of <italic>Sp1.</italic> Three independent experiments were conducted. Student&#x2019;s t-test was performed. <sup>&#x2217;</sup>, P &#x003C; 0.05; <sup>&#x2217;&#x2217;</sup>, P &#x003C; 0.01.</p></caption>
<graphic xlink:href="170084v1_fig3.tif"/>
</fig>
</sec>
<sec id="s3e">
<title>Estrogen negatively regulated gene expression via ER&#x03B2;</title>
<p>Estrogen is an important endocrine regulator of bone metabolism, which mediates it effects via ERs [<xref ref-type="bibr" rid="c18">18</xref>]. ERs are transcription factors that bind EREs to activate or repress target gene expression [<xref ref-type="bibr" rid="c19">19</xref>]. Two mammalian ERs have been identified, ER&#x03B1; and ER&#x03B2; [<xref ref-type="bibr" rid="c20">20</xref>]. Previous studies revealed that estrogen represses <italic>SOST</italic> expression via ER&#x03B2; [<xref ref-type="bibr" rid="c21">21</xref>]. To investigate if the differential gene expression in the E2-treated MC3T3-E1cells was mediated via ER&#x03B2;, we analyzed the <italic>Bmpr1a</italic> and<italic>Tgfbr1</italic> promoters using online bioinformatics software (<ext-link ext-link-type="uri" xlink:href="http://jaspar.binf.ku.dk/">http://jaspar.binf.ku.dk/</ext-link>). The results identified three EREs and two EREs in the <italic>Bmpr1a</italic> and <italic>Tgfbr1</italic>gene promoters, respectively (<xref ref-type="fig" rid="fig4">Fig. 4A</xref>). To determine if E2 repressed the candidate genes via a particular ER, we treated MC3T3-E1cells with 10nM E2, then added the ER&#x03B1; antagonist MPP or the ER&#x03B2; antagonist PTHPP. We then performed qRT-PCR to investigate candidate gene expression. We found that E2 treatment significantly down-regulated <italic>Bmpr1a</italic> and <italic>Tgfbr1</italic>, compared to their expression in the DMSO control groups, in the MC3T3-E1 cells (<xref ref-type="fig" rid="fig4">Fig.4B-D</xref>). MPP did not rescue the E2-mediated down-regulation of <italic>Bmpr1a</italic> and <italic>Tgfbr1</italic> (<xref ref-type="fig" rid="fig4">Fig. 4B-D</xref>). However, PTHPP treatment rescued the down-regulation of <italic>Bmpr1a</italic> and <italic>Tgfbr1</italic> (<xref ref-type="fig" rid="fig4">Fig. 4B-D</xref>). Rescue of the candidate target gene expression by PTHPP, but not MPP, revealed that estrogen negatively regulates gene expression via ER&#x03B2;.</p>
<fig id="fig4" position="float" fig-type="figure">
<label>Figure 4</label>
<caption>
<p>Estrogen negatively regulated gene expression via ER&#x03B2;. (A) Promoter analysis for<italic>Bmpr1a</italic>, <italic>Tgfbr1</italic>, and <italic>Lrp6.</italic> T. MC3T3-E1cells were treated with 10nM E2, and 0.1&#x03BC;M MPP or 0.1&#x03BC;M PTHPP, then candidate target gene mRNA levels were quantified via qRT-PCR. (B) The expression level of <italic>Bmpr1a</italic> under different treatment conditions. (C) The expression level of <italic>Tgfbr1</italic> under different treatment conditions. Three independent experiments were conducted. Student&#x2019;s t test was performed. <sup>&#x2217;</sup>, P &#x003C; 0.05; <sup>&#x2217;&#x2217;</sup>, P &#x003C; 0.01; NS, not significant.</p></caption>
<graphic xlink:href="170084v1_fig4.tif"/>
</fig>
</sec>
<sec id="s3f">
<title>E2 increased ER&#x03B2; binding to the EREs of the <italic>Bmpr1a</italic> and <italic>Tgfb1</italic> promoters in MC3T3-E1cells</title>
<p>We next addressed the potential functionality of the EREs located in the <italic>Bmpr1a</italic> and <italic>Tgfbr1</italic> promoters. We performed ChIP experiments using an ER&#x03B2; antibody to determine if ER&#x03B2; bound to the EREs in the <italic>Bmpr1a</italic> and <italic>Tgfbr1</italic> promoters. We found that ER&#x03B2; bound to ERE1 and ERE3, but not ERE2, in the <italic>Bmpr1a</italic> promoter (<xref ref-type="fig" rid="fig5">Fig. 5A</xref>). Both of the EREs located in the <italic>Tgfbr1</italic> promoter were bound by ER&#x03B2; (<xref ref-type="fig" rid="fig5">Fig. 5B</xref>). To investigate if E2 treatment affected the binding of ER&#x03B2; in the <italic>Bmpr1a</italic> and <italic>Tgfbr1</italic> promoters, we treated the MC3T3-E1 cells with E2 for 72h, then performed ChIP, followed by qRT-PCR. E2 treatment increased ER&#x03B2; binding to ERE1 and ERE3 in the <italic>Bmpr1a</italic> promoter (Fig. 6C), and ERE1 and ERE2 in the <italic>Tgfbr1</italic> promoter (<xref ref-type="fig" rid="fig5">Fig. 5D</xref>). These data demonstrated that ER&#x03B2; can bind to the <italic>Bmpr1a</italic> and <italic>Tgfbr1</italic> promoters, and that E2 increased ER&#x03B2; binding to the EREs of the <italic>Bmpr1a</italic> and <italic>Tgfbr1</italic> promoters in MC3T3-E1cells.</p>
<fig id="fig5" position="float" fig-type="figure">
<label>Figure 5</label>
<caption>
<p>E2 increased ER&#x03B2; binding to the EREs located in the <italic>Bmpr1a</italic> and <italic>Tgfbr1</italic> promoters in MC3T3-E1cells. We performed ChIP experiments on MC3T3-E1cells using an ER&#x03B2; antibody. (A) ER&#x03B2; binding to the ERE1 and ERE3, but not ERE2, located in the<italic>Bmpr1a</italic> promoter. (B) ER&#x03B2; binding to the ERE1 and ERE2 located in the <italic>Tgfbr1</italic> promoter. We performed qRT-PCR after ChIP on cells treated with E2. (C) E2 increased ER&#x03B2; binding to the <italic>Bmpr1a</italic> promoter. (D) E2 increased ER&#x03B2; binding to the <italic>Tgfbr1</italic> promoter. Three independent experiments were conducted. Student&#x2019;s t-test was performed. <sup>&#x2217;</sup>, P&#x003C;0.05; <sup>&#x2217;&#x2217;</sup>, P&#x003C;0.01.</p></caption>
<graphic xlink:href="170084v1_fig5.tif"/>
</fig>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<p>E2, a synthetic, exogenous estrogen that is functionally similar to endogenous estrogen, is commonly used to study the function of estrogen. MC3T3-E1 cells are a newborn mouse calvarias cell line, which is commonly used in the study of osteoblasts. ER&#x03B1; and ER&#x03B2; have also been identified in this cell line, so MC3T3-E1 can be used to study the role of estrogen in the regulation of osteoblast function.</p>
<p>We found that estrogen increases the rates of proliferation and apoptosis in MC3T3-E1 cells. We used CCK-8 and TUNEL assays to investigate the proliferation and apoptosis of MC3T3-E1 cells after E2 treatment. We found no significant differences in the groups treated with low concentrations of E2 after three days. However, high concentrations of E2 promoted the proliferation and apoptosis of MC3T3-E1 cells. E2-mediated increases in the proliferation of MC3T3-E1 cells have been reported in previous studies[<xref ref-type="bibr" rid="c22">22</xref>, <xref ref-type="bibr" rid="c23">23</xref>], but we also found a slight but statistically significant increase in the number of apoptotic cells in our high concentration group, which indicated that treatment with E2 for three days was slightly toxic to MC3T3-E1 cells.</p>
<p>Estrogen affects many signaling pathways that are associated with bone metabolism. In both transcriptome libraries, these pathways can be identified by GO enrichment and KEGG pathway analysis of the DEGs. After E2 treatment of the MC3T3-E1 cells, cell differentiation-and cell cycle-related genes were significantly enriched among the DEGs. The involvement of these pathways can explain why E2-treated MC3T3-E1 cells undergo increased cell proliferation and apoptosis. KEGG signaling pathway analysis indicated that genes in the Wnt, MAPK, and calcium signaling pathways, and osteoclast differentiation genes, were significantly enriched among the DEGs. The enrichment of genes in these bone metabolic pathways among the DEGs demonstrated osteoblast-like differentiation of the MC3T3-E1 cells.</p>
<p>However, in our sequencing results, in addition to these signaling pathways, we found that the TGF-&#x03B2; signaling pathway and cancer-related signaling pathways were also enriched, in contrast with the research of Zhen et al. The TGF-&#x03B2; signaling pathway plays an important role in bone differentiation, especially in osteogenesis [<xref ref-type="bibr" rid="c24">24</xref>]. The TGF-&#x03B2; superfamily of ligands includes BMPs, growth and differentiation factors, anti-m&#x00FC;llerian hormone, activin, nodal, and the TGF-&#x03B2; proteins [<xref ref-type="bibr" rid="c25">25</xref>]. Signaling begins with the binding of a TGF-&#x03B2; superfamily ligand to a TGF-&#x03B2; type II receptor [<xref ref-type="bibr" rid="c26">26</xref>]. The type II receptor is a serine/threonine receptor kinase, which catalyzes the phosphorylation of the type I receptor [<xref ref-type="bibr" rid="c25">25</xref>]. Each class of ligand binds to a specific type II receptor. In mammals, there are seven known type I receptors and five type II receptors [<xref ref-type="bibr" rid="c25">25</xref>]. In our sequencing results, we found that <italic>Tgfbr1</italic> and <italic>Bmpr1a</italic> levels were significantly reduced in MC3T3-E1 cells after E2 treatment, and qRT-PCR confirmed this result. <italic>Tgfbr1</italic>is also called activin receptor-like kinase receptor (<italic>Alk5)</italic> [<xref ref-type="bibr" rid="c27">27</xref>], ALK5 protein is strongly expressed in perichondrial progenitor cells for osteoblasts, and in a thin chondrocyte layer located adjacent to the perichondrium in the peripheral cartilage [<xref ref-type="bibr" rid="c28">28</xref>]. Conditional knockout of the TGF-&#x03B2; type I receptor <italic>Alk5</italic> in skeletal progenitor cells resulted in growth plates that had an abnormally thin perichondrial cell layer, as well as reduced proliferation and differentiation of osteoblasts [<xref ref-type="bibr" rid="c29">29</xref>].</p>
<p>The BMP receptors are a family of transmembrane serine/threonine kinases that include the type I receptors <italic>Bmpr1a</italic> and <italic>Bmpr1b</italic>, and the type II receptor Bmpr2 [<xref ref-type="bibr" rid="c25">25</xref>, <xref ref-type="bibr" rid="c30">30</xref>]. Deletion of the receptor <italic>Bmpr1a</italic> in osteoblast lineage cells with a <italic>Dmp1</italic>-Cre caused a dramatic increase in trabecular bone mass in postnatal mice, which was due to a marked increase in osteoblast numbers. In addition to increasing the osteoblast numbers in the trabecular bone. [<xref ref-type="bibr" rid="c31">31</xref>]. Another study revealed that conditional deletion of <italic>Bmpr1a</italic> in differentiated osteoclasts negatively regulates osteoclast differentiation. However, osteoblast-specific deletion of <italic>Bmpr1a</italic> resulted in increased bone volume with marked decreases in BFR in tibias at eight weeks of age [<xref ref-type="bibr" rid="c32">32</xref>, <xref ref-type="bibr" rid="c33">33</xref>].Thus, physiological <italic>Bmpr1a</italic> signaling in bone exerts a dual function in both restricting pre-osteoblast proliferation and promoting osteoblast activity. If the impact of decreased <italic>Tgfbr1</italic> and <italic>Bmpr1a</italic> expression on MC3T3-E1 cell differentiation or increasing osteoclast activity must be further explored.</p>
<p>Cancer-related signaling pathways are the second most abundantly enriched type of signaling pathway in our DEGs, and many types of cancers relative signaling are enriched, including colorectal cancer, pancreatic cancer, non-small cell lung cancer, endometrial cancer, and prostate cancer. This is consistent with clinical findings: estrogen is commonly used as a compensatory drug for estrogen loss, after long-term estrogen treatment estrogen in the initiation of many type cancer [<xref ref-type="bibr" rid="c34">34</xref>&#x2013;<xref ref-type="bibr" rid="c36">36</xref>]. Although estrogen is an effective clinical treatment for postmenopausal osteoporosis and other estrogen deficiency-related diseases, its negative role cannot be ignored.</p>
<p>Estrogen inhibits the expression of <italic>Tgfbr1</italic> and <italic>Bmpr1a</italic> through ER&#x03B2;. Previous studies have also shown that estrogen can inhibit the expression of <italic>SOST</italic> through ER&#x03B2; [<xref ref-type="bibr" rid="c21">21</xref>]. To confirm that estrogen inhibits the expression of <italic>Tgfbr1</italic> and <italic>Bmpr1a</italic> through ER&#x03B2;, we used ER&#x03B1;- and ER&#x03B2;-specific inhibitors, and found that only the ER&#x03B2; inhibitor rescued the expression of <italic>Tgfbr1</italic> and <italic>Bmpr1a.</italic> In addition, our ChIP experiment also demonstrated that ER&#x03B2; binds to the <italic>Tgfbr1</italic> and <italic>Bmpr1a</italic> promoters. In mouse lung cancer tissue, estrogen was found to inhibit the expression of <italic>Bmpr2</italic> through ER&#x03B1; [<xref ref-type="bibr" rid="c37">37</xref>]. Estrogen also inhibits the activity of the TGF-&#x03B2; signaling pathway by promoting Smad2/3 degradation [<xref ref-type="bibr" rid="c38">38</xref>]. In another study, estrogen replacement decreases the accumulation of TGF-&#x03B2;1 on vascular smooth muscle cell (VSMC) [<xref ref-type="bibr" rid="c39">39</xref>]. In this study, we found that the ER signaling pathway and the TGF-&#x03B2; signaling pathway participate in crosstalk, and ER&#x03B2; can inhibit <italic>Tgfbr1.</italic> Therefore, estrogen can down-regulate the expression of <italic>Tgfbr1</italic> and <italic>Bmpr1a</italic> in MC3T3-E1 cells.</p>
</sec>
<sec id="s5">
<title>Conclusions</title>
<p>In conclusion, estrogen can affect bone metabolism via several bone metabolism-related signaling pathways. In MC3T3-E1 cells, estrogen appears to affect bone by negatively regulating <italic>Tgfbr1</italic> and <italic>Bmpr1a</italic> expression. Our research provides a new understanding of the mechanism by which estrogen acts on osteoblasts.</p>
</sec>
</body>
<back>
<sec>
<title>Compliance with ethical standards</title>
<sec>
<title>Conflict of interest</title>
<p>The authors declare that they have no conflict of interest.</p>
</sec>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>[1]</label> <mixed-citation publication-type="journal"><string-name><surname>Lokuge</surname> <given-names>S</given-names></string-name>, <string-name><surname>Frey</surname> <given-names>BN</given-names></string-name>, <string-name><surname>Foster</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Soares</surname> <given-names>CN</given-names></string-name>, <string-name><surname>Steiner</surname> <given-names>M.</given-names></string-name> <article-title>The rapid effects of estrogen: a mini-review</article-title>. <source>Behavioural pharmacology</source>. <year>2010</year>;<volume>21</volume>:<fpage>465</fpage>&#x2013;<lpage>72</lpage>.</mixed-citation></ref>
<ref id="c2"><label>[2]</label> <mixed-citation publication-type="journal"><string-name><surname>Ryan</surname> <given-names>KJ.</given-names></string-name> <article-title>Biochemistry of aromatase: significance to female reproductive physiology</article-title>. <source>Cancer research</source>. <year>1982</year>;<volume>42</volume>:<fpage>3342s</fpage>&#x2013;<lpage>4s</lpage>.</mixed-citation></ref>
<ref id="c3"><label>[3]</label> <mixed-citation publication-type="journal"><string-name><surname>Tanapat</surname> <given-names>P</given-names></string-name>, <string-name><surname>Hastings</surname> <given-names>NB</given-names></string-name>, <string-name><surname>Reeves</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Gould</surname> <given-names>E.</given-names></string-name> <article-title>Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat</article-title>. <source>The Journal of neuroscience: the official journal of the Society for Neuroscience.</source> <year>1999</year>;<volume>19</volume>:<fpage>5792</fpage>&#x2013;<lpage>801</lpage>.</mixed-citation></ref>
<ref id="c4"><label>[4]</label> <mixed-citation publication-type="journal"><string-name><surname>Riggs</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Spelsberg</surname> <given-names>TC.</given-names></string-name> <article-title>Mechanisms of estrogen action on bone</article-title>. <source>Postgraduate medicine</source>.<year>1989</year>;SpecNo:13-4; discussion 33-43.</mixed-citation></ref>
<ref id="c5"><label>[5]</label> <mixed-citation publication-type="journal"><string-name><surname>Zhu</surname> <given-names>BT</given-names></string-name>, <string-name><surname>Conney</surname>, <given-names>AH.</given-names></string-name> <article-title>Functional role of estrogen metabolism in target cells: review and perspectives</article-title>. <source>Carcinogenesis.</source> <year>1998</year>;<volume>19</volume>:<fpage>1</fpage>&#x2013;<lpage>27</lpage>.</mixed-citation></ref>
<ref id="c6"><label>[6]</label> <mixed-citation publication-type="journal"><string-name><surname>Khosla</surname> <given-names>S</given-names></string-name>, <string-name><surname>Riggs</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Atkinson</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Oberg</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Mavilia</surname> <given-names>C</given-names></string-name>, <string-name><surname>Del Monte</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal> <article-title>Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men</article-title>. <source>The Journal of clinical endocrinology and metabolism.</source> <year>2004</year>;<volume>89</volume>:<fpage>1808</fpage>&#x2013;<lpage>16</lpage>.</mixed-citation></ref>
<ref id="c7"><label>[7]</label> <mixed-citation publication-type="journal"><string-name><surname>Kanis</surname> <given-names>JA.</given-names></string-name> <article-title>Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report</article-title>. <source>WHO Study Group. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.</source> <year>1994</year>;<volume>4</volume>:<fpage>368</fpage>&#x2013;<lpage>81</lpage>.</mixed-citation></ref>
<ref id="c8"><label>[8]</label> <mixed-citation publication-type="journal"><string-name><surname>Tanaka</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Nakayamada</surname> <given-names>S</given-names></string-name>, <string-name><surname>Okada</surname>, <given-names>Y.</given-names></string-name> <article-title>Osteoblasts and osteoclasts in bone remodeling and inflammation</article-title>. <source>Current drug targets Inflammation and allergy.</source> <year>2005</year>;<volume>4</volume>:<fpage>325</fpage>&#x2013;<lpage>8</lpage>.</mixed-citation></ref>
<ref id="c9"><label>[9]</label> <mixed-citation publication-type="journal"><string-name><surname>Harvey</surname> <given-names>N</given-names></string-name>, <string-name><surname>Dennison</surname> <given-names>E</given-names></string-name>, <string-name><surname>Cooper</surname> <given-names>C.</given-names></string-name> <article-title>Osteoporosis: impact on health and economics</article-title>. <source>Nature reviews Rheumatology.</source> <year>2010</year>;<volume>6</volume>:<fpage>99</fpage>&#x2013;<lpage>105</lpage>.</mixed-citation></ref>
<ref id="c10"><label>[10]</label> <mixed-citation publication-type="journal"><string-name><surname>Oursler</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Osdoby</surname> <given-names>P</given-names></string-name>, <string-name><surname>Pyfferoen</surname> <given-names>J</given-names></string-name>, <string-name><surname>Riggs</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Spelsberg</surname> <given-names>TC.</given-names></string-name> <article-title>Avian osteoclasts as estrogen target cells</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America.</source> <year>1991</year>;<volume>88</volume>:<fpage>6613</fpage>&#x2013;<lpage>7</lpage>.</mixed-citation></ref>
<ref id="c11"><label>[11]</label> <mixed-citation publication-type="journal"><string-name><surname>Martin-Millan</surname> <given-names>M</given-names></string-name>, <string-name><surname>Almeida</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ambrogini</surname> <given-names>E</given-names></string-name>, <string-name><surname>Han</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>H</given-names></string-name>, <string-name><surname>Weinstein</surname> <given-names>RS</given-names></string-name>, <etal>et al.</etal> <article-title>The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone</article-title>. <source>Molecular endocrinology.</source> <year>2010</year>;<volume>24</volume>:<fpage>323</fpage>&#x2013;<lpage>34</lpage>.</mixed-citation></ref>
<ref id="c12"><label>[12]</label> <mixed-citation publication-type="journal"><string-name><surname>TeraTde</surname> <given-names>M</given-names></string-name>, <string-name><surname>Prado</surname> <given-names>RF</given-names></string-name>, <string-name><surname>De Marco</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Santamaria</surname> <given-names>MP</given-names></string-name>, <string-name><surname>Jardini</surname> <given-names>MA.</given-names></string-name> <article-title>The RANK/ RANKL/ OPG interaction in the repair of autogenous bone grafts in female rats with estrogen deficiency</article-title>. <source>Brazilian oral research.</source> <year>2014</year>;<fpage>28</fpage>.</mixed-citation></ref>
<ref id="c13"><label>[13]</label> <mixed-citation publication-type="journal"><string-name><surname>Srivastava</surname> <given-names>S</given-names></string-name>, <string-name><surname>Toraldo</surname> <given-names>G</given-names></string-name>, <string-name><surname>Weitzmann</surname> <given-names>MN</given-names></string-name>, <string-name><surname>Cenci</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ross</surname> <given-names>FP</given-names></string-name>, <string-name><surname>Pacifici</surname> <given-names>R.</given-names></string-name> <article-title>Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation</article-title>. <source>The Journal of biological chemistry.</source> <year>2001</year>;<volume>276</volume>:<fpage>8836</fpage>&#x2013;<lpage>40</lpage>.</mixed-citation></ref>
<ref id="c14"><label>[14]</label> <mixed-citation publication-type="journal"><string-name><surname>Robinson</surname> <given-names>LJ</given-names></string-name>, <string-name><surname>Yaroslavskiy</surname> <given-names>BB</given-names></string-name>, <string-name><surname>Griswold</surname> <given-names>RD</given-names></string-name>, <string-name><surname>Zadorozny</surname> <given-names>EV</given-names></string-name>, <string-name><surname>Guo</surname> <given-names>L</given-names></string-name>, <string-name><surname>Tourkova</surname> <given-names>IL</given-names></string-name>, <etal>et al.</etal> <article-title>Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-alpha with BCAR1 and Traf6</article-title>. <source>Experimental cell research.</source> <year>2009</year>;<volume>315</volume>:<fpage>1287</fpage>&#x2013;<lpage>301</lpage>.</mixed-citation></ref>
<ref id="c15"><label>[15]</label> <mixed-citation publication-type="journal"><string-name><surname>Ammann</surname> <given-names>P</given-names></string-name>, <string-name><surname>Rizzoli</surname> <given-names>R</given-names></string-name>, <string-name><surname>Bonjour</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Bourrin</surname> <given-names>S</given-names></string-name>, <string-name><surname>Meyer</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Vassalli</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> <article-title>Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency</article-title>. <source>The Journal of clinical investigation.</source> <year>1997</year>;<volume>99</volume>:<fpage>1699</fpage>&#x2013;<lpage>703</lpage>.</mixed-citation></ref>
<ref id="c16"><label>[16]</label> <mixed-citation publication-type="journal"><string-name><surname>Kimble</surname> <given-names>RB</given-names></string-name>, <string-name><surname>Srivastava</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ross</surname> <given-names>FP</given-names></string-name>, <string-name><surname>Matayoshi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Pacifici</surname> <given-names>R.</given-names></string-name> <article-title>Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production</article-title>. <source>The Journal of biological chemistry.</source> <year>1996</year>;<volume>271</volume>:<fpage>28890</fpage>&#x2013;<lpage>7</lpage>.</mixed-citation></ref>
<ref id="c17"><label>[17]</label> <mixed-citation publication-type="journal"><string-name><surname>Kimble</surname> <given-names>RB</given-names></string-name>, <string-name><surname>Vannice</surname>, <given-names>JL</given-names></string-name>, <string-name><surname>Bloedow</surname> <given-names>DC</given-names></string-name>, <string-name><surname>Thompson</surname> <given-names>RC</given-names></string-name>, <string-name><surname>Hopfer</surname> <given-names>W</given-names></string-name>, <string-name><surname>Kung</surname> <given-names>VT</given-names></string-name>, <etal>et al.</etal> <article-title>Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats</article-title>. <source>The Journal of clinical investigation.</source> <year>1994</year>;<volume>93</volume>:<fpage>1959</fpage>&#x2013;<lpage>67</lpage>.</mixed-citation></ref>
<ref id="c18"><label>[18]</label> <mixed-citation publication-type="journal"><string-name><surname>Kitazawa</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kimble</surname> <given-names>RB</given-names></string-name>, <string-name><surname>Vannice</surname>, <given-names>JL</given-names></string-name>, <string-name><surname>Kung</surname> <given-names>VT</given-names></string-name>, <string-name><surname>Pacifici</surname> <given-names>R.</given-names></string-name> <article-title>Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice</article-title>. <source>The Journal of clinical investigation.</source> <year>1994</year>;<volume>94</volume>:<fpage>2397</fpage>&#x2013;<lpage>406</lpage>.</mixed-citation></ref>
<ref id="c19"><label>[19]</label> <mixed-citation publication-type="journal"><string-name><surname>Komm</surname> <given-names>BS</given-names></string-name>, <string-name><surname>Terpening</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Benz</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Graeme</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Gallegos</surname> <given-names>A</given-names></string-name>, <string-name><surname>Korc</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells</article-title>. <source>Science.</source> <year>1988</year>;<volume>241</volume>:<fpage>81</fpage>&#x2013;<lpage>4</lpage>.</mixed-citation></ref>
<ref id="c20"><label>[20]</label> <mixed-citation publication-type="journal"><string-name><surname>Kousteni</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bellido</surname> <given-names>T</given-names></string-name>, <string-name><surname>Plotkin</surname> <given-names>LI</given-names></string-name>, <string-name><surname>O&#x2019;Brien</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Bodenner</surname> <given-names>DL</given-names></string-name>, <string-name><surname>Han</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity</article-title>. <source>Cell.</source> <year>2001</year>;<volume>104</volume>:<fpage>719</fpage>&#x2013;<lpage>30</lpage>.</mixed-citation></ref>
<ref id="c21"><label>[21]</label> <mixed-citation publication-type="journal"><string-name><surname>Kousteni</surname> <given-names>S</given-names></string-name>, <string-name><surname>Han</surname> <given-names>L</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Almeida</surname> <given-names>M</given-names></string-name>, <string-name><surname>Plotkin</surname> <given-names>LI</given-names></string-name>, <string-name><surname>Bellido</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal> <article-title>Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids</article-title>. <source>The Journal of clinical investigation.</source> <year>2003</year>;<volume>111</volume>:<fpage>1651</fpage>&#x2013;<lpage>64</lpage>.</mixed-citation></ref>
<ref id="c22"><label>[22]</label> <mixed-citation publication-type="journal"><string-name><surname>Chang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Tang</surname> <given-names>E</given-names></string-name>, <string-name><surname>Fan</surname> <given-names>Z</given-names></string-name>, <string-name><surname>McCauley</surname> <given-names>L</given-names></string-name>, <string-name><surname>Franceschi</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> <article-title>Inhibition of osteoblastic bone formation by nuclear factor-kappaB</article-title>. <source>Nature medicine.</source> <year>2009</year>;<volume>15</volume>:<fpage>682</fpage>&#x2013;<lpage>9</lpage>.</mixed-citation></ref>
<ref id="c23"><label>[23]</label> <mixed-citation publication-type="journal"><string-name><surname>Bhalerao</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bogers</surname> <given-names>J</given-names></string-name>, <string-name><surname>Van Marck</surname> <given-names>E</given-names></string-name>, <string-name><surname>Merregaert</surname> <given-names>J.</given-names></string-name> <article-title>Establishment and characterization of two clonal cell lines derived from murine mandibular condyles</article-title>. <source>Tissue &#x0026; cell.</source> <year>1995</year>;<volume>27</volume>:<fpage>369</fpage>&#x2013;<lpage>82</lpage>.</mixed-citation></ref>
<ref id="c24"><label>[24]</label> <mixed-citation publication-type="journal"><string-name><surname>Schlicker</surname> <given-names>A</given-names></string-name>, <string-name><surname>Domingues</surname> <given-names>FS</given-names></string-name>, <string-name><surname>Rahnenfuhrer</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lengauer</surname>, <given-names>T.</given-names></string-name> <article-title>A new measure for functional similarity of gene products based on Gene Ontology</article-title>. <source>BMC bioinformatics</source>. <year>2006</year>;<volume>7</volume>:<fpage>302</fpage>.</mixed-citation></ref>
<ref id="c25"><label>[25]</label> <mixed-citation publication-type="journal"><string-name><surname>Du</surname> <given-names>J</given-names></string-name>, <string-name><surname>Yuan</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Ma</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Song</surname> <given-names>J</given-names></string-name>, <string-name><surname>Xie</surname> <given-names>X</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>Y</given-names></string-name> <article-title>KEGG-PATH: Kyoto encyclopedia of genes and genomes-based pathway analysis using a path analysis model</article-title>. <source>Molecular bioSystems.</source> <year>2014</year>;<volume>10</volume>:<fpage>2441</fpage>&#x2013;<lpage>7</lpage>.</mixed-citation></ref>
<ref id="c26"><label>[26]</label> <mixed-citation publication-type="journal"><string-name><surname>Riddell</surname> <given-names>N</given-names></string-name>, <string-name><surname>Crewther</surname>, <given-names>SG.</given-names></string-name> <article-title>Integrated Comparison of GWAS, Transcriptome, and Proteomics Studies Highlights Similarities in the Biological Basis of Animal and Human Myopia</article-title>. <source>Investigative ophthalmology &#x0026; visual science.</source> <year>2017</year>;<volume>58</volume>:<fpage>660</fpage>&#x2013;<lpage>9</lpage>.</mixed-citation></ref>
<ref id="c27"><label>[27]</label> <mixed-citation publication-type="journal"><string-name><surname>Ghosh</surname> <given-names>S</given-names></string-name>, <string-name><surname>Chan</surname> <given-names>CK.</given-names></string-name> <article-title>Analysis of RNA-Seq Data Using TopHat and Cufflinks</article-title>. <source>Methods in molecular biology.</source> <year>2016</year>;<volume>1374</volume>:<fpage>339</fpage>&#x2013;<lpage>61</lpage>.</mixed-citation></ref>
<ref id="c28"><label>[28]</label> <mixed-citation publication-type="journal"><string-name><surname>Cooke</surname> <given-names>PS</given-names></string-name>, <string-name><surname>Buchanan</surname> <given-names>DL</given-names></string-name>, <string-name><surname>Lubahn</surname> <given-names>DB</given-names></string-name>, <string-name><surname>Cunha</surname> <given-names>GR.</given-names></string-name> <article-title>Mechanism of estrogen action: lessons from the estrogen receptor-alpha knockout mouse</article-title>. <source>Biology of reproduction.</source> <year>1998</year>;<volume>59</volume>:<fpage>470</fpage>&#x2013;<lpage>5</lpage>.</mixed-citation></ref>
<ref id="c29"><label>[29]</label> <mixed-citation publication-type="journal"><string-name><surname>Klinge</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Bodenner</surname> <given-names>DL</given-names></string-name>, <string-name><surname>Desai</surname> <given-names>D</given-names></string-name>, <string-name><surname>Niles</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Traish</surname> <given-names>AM.</given-names></string-name> <article-title>Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro</article-title>. <source>Nucleic acids research.</source> <year>1997</year>;<volume>25</volume>:<fpage>1903</fpage>&#x2013;<lpage>12</lpage>.</mixed-citation></ref>
<ref id="c30"><label>[30]</label> <mixed-citation publication-type="journal"><string-name><surname>Galea</surname> <given-names>GL</given-names></string-name>, <string-name><surname>Meakin</surname>, <given-names>LB</given-names></string-name>, <string-name><surname>Sugiyama</surname> <given-names>T</given-names></string-name>, <string-name><surname>Zebda</surname> <given-names>N</given-names></string-name>, <string-name><surname>Sunters</surname> <given-names>A</given-names></string-name>, <string-name><surname>Taipaleenmaki</surname> <given-names>H</given-names></string-name>, <etal>et al.</etal> <article-title>Estrogen receptor alpha mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor beta</article-title>. <source>The Journal of biological chemistry.</source> <year>2013</year>;<volume>288</volume>:<fpage>9035</fpage>&#x2013;<lpage>48</lpage>.</mixed-citation></ref>
<ref id="c31"><label>[31]</label> <mixed-citation publication-type="journal"><string-name><surname>Kanatani</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sugimoto</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kano</surname> <given-names>J</given-names></string-name>, <string-name><surname>Fukase</surname> <given-names>M</given-names></string-name>, <string-name><surname>Fujita</surname> <given-names>T.</given-names></string-name> <article-title>Effect of 17 beta-estradiol on the proliferation of osteoblastic MC3T3-E1 cells via human monocytes</article-title>. <source>Biochemical and biophysical research communications.</source> <year>1991</year>;<volume>178</volume>:<fpage>866</fpage>&#x2013;<lpage>70</lpage>.</mixed-citation></ref>
<ref id="c32"><label>[32]</label> <mixed-citation publication-type="journal"><string-name><surname>Kanno</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hirano</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kayama</surname> <given-names>F.</given-names></string-name> <article-title>Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells</article-title>. <source>Toxicology.</source> <year>2004</year>;<volume>196</volume>:<fpage>137</fpage>&#x2013;<lpage>45</lpage>.</mixed-citation></ref>
<ref id="c33"><label>[33]</label> <mixed-citation publication-type="journal"><string-name><surname>Shang</surname> <given-names>ZZ</given-names></string-name>, <string-name><surname>Li</surname> <given-names>X</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>HQ</given-names></string-name>, <string-name><surname>Xiao</surname> <given-names>GN</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>CW</given-names></string-name>, <string-name><surname>Gong</surname> <given-names>Q.</given-names></string-name> <article-title>Differentially expressed genes and signalling pathways are involved in mouse osteoblast-like MC3T3-E1 cells exposed to 17-beta estradiol</article-title>. <source>International journal of oral science.</source> <year>2014</year>;<volume>6</volume>:<fpage>142</fpage>&#x2013;<lpage>9</lpage>.</mixed-citation></ref>
<ref id="c34"><label>[34]</label> <mixed-citation publication-type="journal"><string-name><surname>Wu</surname> <given-names>M</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>G</given-names></string-name>, <string-name><surname>Li</surname> <given-names>YP.</given-names></string-name> <article-title>TGF-beta and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease</article-title>. <source>Bone research</source>. <year>2016</year>;<volume>4</volume>:<fpage>16009</fpage>.</mixed-citation></ref>
<ref id="c35"><label>[35]</label> <mixed-citation publication-type="journal"><string-name><surname>Shi</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Massague</surname> <given-names>J.</given-names></string-name> <article-title>Mechanisms of TGF-beta signaling from cell membrane to the nucleus</article-title>. <source>Cell.</source> <year>2003</year>;<volume>113</volume>:<fpage>685</fpage>&#x2013;<lpage>700</lpage>.</mixed-citation></ref>
<ref id="c36"><label>[36]</label> <mixed-citation publication-type="journal"><string-name><surname>Massague</surname> <given-names>J</given-names></string-name>, <string-name><surname>Gomis</surname> <given-names>RR.</given-names></string-name> <article-title>The logic of TGFbeta signaling</article-title>. <source>FEBS letters.</source> <year>2006</year>;<volume>580</volume>:<fpage>2811</fpage>&#x2013;<lpage>20</lpage>.</mixed-citation></ref>
<ref id="c37"><label>[37]</label> <mixed-citation publication-type="journal"><string-name><surname>Moustakas</surname> <given-names>A.</given-names></string-name> <article-title>Smad signalling network</article-title>. <source>Journal of cell science.</source> <year>2002</year>;<volume>115</volume>:<fpage>3355</fpage>&#x2013;<lpage>6</lpage>.</mixed-citation></ref>
<ref id="c38"><label>[38]</label> <mixed-citation publication-type="journal"><string-name><surname>Zhong</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Williams</surname> <given-names>BO.</given-names></string-name> <article-title>Integration of cellular adhesion and Wnt signaling: Interactions between N-cadherin and LRP5 and their role in regulating bone mass</article-title>. <source>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research.</source> <year>2012</year>;<volume>27</volume>:<fpage>1849</fpage>&#x2013;<lpage>51</lpage>.</mixed-citation></ref>
<ref id="c39"><label>[39]</label> <mixed-citation publication-type="journal"><string-name><surname>Hosseini-Farahabadi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Geetha-Loganathan</surname> <given-names>P</given-names></string-name>, <string-name><surname>Fu</surname> <given-names>K</given-names></string-name>, <string-name><surname>Nimmagadda</surname> <given-names>S</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Richman</surname> <given-names>JM.</given-names></string-name> <article-title>Dual functions for WNT5A during cartilage development and in disease</article-title>. <source>Matrix biology journal of the International Society for Matrix Biology.</source> <year>2013</year>;<volume>32</volume>:<fpage>252</fpage>&#x2013;<lpage>64</lpage>.</mixed-citation></ref>
<ref id="c40"><label>[40]</label> <mixed-citation publication-type="journal"><string-name><surname>Matsunobu</surname> <given-names>T</given-names></string-name>, <string-name><surname>Torigoe</surname> <given-names>K</given-names></string-name>, <string-name><surname>Ishikawa</surname> <given-names>M</given-names></string-name>, <string-name><surname>de Vega</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kulkarni</surname> <given-names>AB</given-names></string-name>, <string-name><surname>Iwamoto</surname> <given-names>Y</given-names></string-name>, <etal>et al.</etal> <article-title>Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development</article-title>. <source>Developmental biology.</source> <year>2009</year>;<volume>332</volume>:<fpage>325</fpage>&#x2013;<lpage>38</lpage>.</mixed-citation></ref>
<ref id="c41"><label>[41]</label> <mixed-citation publication-type="journal"><string-name><surname>Wozney</surname>, <given-names>JM</given-names></string-name>, <string-name><surname>Rosen</surname> <given-names>V</given-names></string-name>, <string-name><surname>Celeste</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Mitsock</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Whitters</surname>, <given-names>MJ</given-names></string-name>, <string-name><surname>Kriz</surname>, <given-names>RW</given-names></string-name>, <etal>et al.</etal> <article-title>Novel regulators of bone formation: molecular clones and activities</article-title>. <source>Science.</source> <year>1988</year>;<volume>242</volume>:<fpage>1528</fpage>&#x2013;<lpage>34</lpage>.</mixed-citation></ref>
<ref id="c42"><label>[42]</label> <mixed-citation publication-type="journal"><string-name><surname>Lim</surname> <given-names>J</given-names></string-name>, <string-name><surname>Shi</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Karner</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>SY</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>WC</given-names></string-name>, <string-name><surname>He</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal> <article-title>Dual function of Bmpr1a signaling in restricting preosteoblast proliferation and stimulating osteoblast activity in mouse</article-title>. <source>Development.</source> <year>2016</year>;<volume>143</volume>:<fpage>339</fpage>&#x2013;<lpage>47</lpage>.</mixed-citation></ref>
<ref id="c43"><label>[43]</label> <mixed-citation publication-type="journal"><string-name><surname>Mishina</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Starbuck</surname> <given-names>MW</given-names></string-name>, <string-name><surname>Gentile</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Fukuda</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kasparcova</surname> <given-names>V</given-names></string-name>, <string-name><surname>Seedor</surname> <given-names>JG</given-names></string-name>, <etal>et al.</etal> <article-title>Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling</article-title>. <source>The Journal of biological chemistry.</source> <year>2004</year>;<volume>279</volume>:<fpage>27560</fpage>&#x2013;<lpage>6</lpage>.</mixed-citation></ref>
<ref id="c44"><label>[44]</label> <mixed-citation publication-type="journal"><string-name><surname>Okamoto</surname> <given-names>M</given-names></string-name>, <string-name><surname>Murai</surname> <given-names>J</given-names></string-name>, <string-name><surname>Imai</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ikegami</surname> <given-names>D</given-names></string-name>, <string-name><surname>Kamiya</surname> <given-names>N</given-names></string-name>, <string-name><surname>Kato</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title>Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice</article-title>. <source>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research.</source> <year>2011</year>;<volume>26</volume>:<fpage>2511</fpage>&#x2013;<lpage>22</lpage>.</mixed-citation></ref>
<ref id="c45"><label>[45]</label> <mixed-citation publication-type="journal"><string-name><surname>Thakkar</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Mehta</surname> <given-names>DG.</given-names></string-name> <article-title>A review of an unfavorable subset of breast cancer: estrogen receptor positive progesterone receptor negative</article-title>. <source>The oncologist.</source> <year>2011</year>;<volume>16</volume>:<fpage>276</fpage>&#x2013;<lpage>85</lpage>.</mixed-citation></ref>
<ref id="c46"><label>[46]</label> <mixed-citation publication-type="journal"><string-name><surname>Russo</surname> <given-names>J</given-names></string-name>, <string-name><surname>Russo</surname> <given-names>IH.</given-names></string-name> <article-title>The role of estrogen in the initiation of breast cancer</article-title>. <source>The Journal of steroid biochemistry and molecular biology.</source> <year>2006</year>;<volume>102</volume>:<fpage>89</fpage>&#x2013;<lpage>96</lpage>.</mixed-citation></ref>
<ref id="c47"><label>[47]</label> <mixed-citation publication-type="journal"><string-name><surname>Nelles</surname>, <given-names>JL</given-names></string-name>, <string-name><surname>Hu</surname> <given-names>WY</given-names></string-name>, <string-name><surname>Prins</surname>, <given-names>GS.</given-names></string-name> <article-title>Estrogen action and prostate cancer</article-title>. <source>Expert review of endocrinology &#x0026; metabolism.</source> <year>2011</year>;<volume>6</volume>:<fpage>437</fpage>&#x2013;<lpage>51</lpage>.</mixed-citation></ref>
<ref id="c48"><label>[48]</label> <mixed-citation publication-type="journal"><string-name><surname>Austin</surname> <given-names>ED</given-names></string-name>, <string-name><surname>Hamid</surname> <given-names>R</given-names></string-name>, <string-name><surname>Hemnes</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Loyd</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Blackwell</surname> <given-names>T</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title>BMPR2 expression is suppressed by signaling through the estrogen receptor</article-title>. <source>Biology of sex differences</source>. <year>2012</year>;<volume>3</volume>:<fpage>6</fpage>.</mixed-citation></ref>
<ref id="c49"><label>[49]</label> <mixed-citation publication-type="journal"><string-name><surname>Ito</surname> <given-names>I</given-names></string-name>, <string-name><surname>Hanyu</surname> <given-names>A</given-names></string-name>, <string-name><surname>Wayama</surname> <given-names>M</given-names></string-name>, <string-name><surname>Goto</surname> <given-names>N</given-names></string-name>, <string-name><surname>Katsuno</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Kawasaki</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title>Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation</article-title>. <source>The Journal of biological chemistry.</source> <year>2010</year>;<volume>285</volume>:<fpage>14747</fpage>&#x2013;<lpage>55</lpage>.</mixed-citation></ref>
<ref id="c50"><label>[50]</label> <mixed-citation publication-type="journal"><string-name><surname>Selzman</surname> <given-names>CH</given-names></string-name>, <string-name><surname>Gaynor</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Turner</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Whitehill</surname> <given-names>TA</given-names></string-name>, <string-name><surname>Horwitz</surname> <given-names>LD</given-names></string-name>, <string-name><surname>Harken</surname> <given-names>AH.</given-names></string-name> <article-title>Estrogen replacement inhibits intimal hyperplasia and the accumulation and effects of transforming growth factor beta1</article-title>. <source>The Journal of surgical research.</source> <year>1998</year>;<volume>80</volume>:<fpage>380</fpage>&#x2013;<lpage>5</lpage>.</mixed-citation></ref>
<ref id="c51"><label>[51]</label> <mixed-citation publication-type="journal"><string-name><surname>Wu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Gathings</surname> <given-names>B</given-names></string-name>, <string-name><surname>Wan</surname> <given-names>M</given-names></string-name>, <string-name><surname>Li</surname> <given-names>X</given-names></string-name>, <string-name><surname>Grizzle</surname> <given-names>W</given-names></string-name>, <etal>et al.</etal> <article-title>Smad4 as a transcription corepressor for estrogen receptor alpha</article-title>. <source>The Journal of biological chemistry.</source> <year>2003</year>;<volume>278</volume>:<fpage>15192</fpage>&#x2013;<lpage>200</lpage>.</mixed-citation></ref>
</ref-list>
</back>
</article>
